Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enzymotec Ltd (NASDAQ:ENZY)

10.50
Delayed Data
As of 1:49pm ET
 +0.03 / +0.29%
Today’s Change
5.38
Today|||52-Week Range
10.83
+37.43%
Year-to-Date

Today’s Trading

Previous close10.47
Today’s open10.39
Day’s range10.15 - 10.53
Volume41,900
Average volume (3 months)24,327
Market cap$236.2M
Dividend yield--
Data as of 1:49pm ET, 09/03/2015

Growth & Valuation

Earnings growth (last year)-76.16%
Earnings growth (this year)-6.62%
Earnings growth (next 5 years)+31.83%
Revenue growth (last year)-27.51%
P/E ratio--
Price/Sales3.76
Price/Book1.84

Competitors

 Today’s
change
Today’s
% change
ONVOOrganovo Holdings In...-0.10-3.79%
VSTMVerastem Inc-0.40-6.46%
CGENCompugen Ltd+0.01+0.20%
--Wang On Group Ltd-0.00-7.14%
Data as of 2:05pm ET, 09/03/2015

Financials

Next reporting dateNovember 12, 2015
EPS forecast (this quarter)$0.07
Annual revenue (last year)$47.1M
Annual profit (last year)$7.8M
Net profit margin16.64%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Ariel Katz
Vice President-
Operations
Yariv Gratz
Corporate headquarters
Migdal HaEmeq, Hazafon

Forecasts

Partner Offers